SemBioSys Genetics Inc. obtains up to $1.5 million in funding... ( CALGARY May 4 / SemBioSys Genetics In...)

SemBioSys Genetics Inc. obtains up to $1.5 million in funding from AVAC

Date:5/4/2009

CALGARY, May 4 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), specializing in the manufacture of high-value proteins and oils in plant seeds, today announced that it has reached an agreement with AVAC Ltd. for a $1.5 million loan for the development of its Apo AIMilano candidate. AVAC is a private, not-for-profit company that invests in research initiatives and early stage commercial businesses that expand Alberta's value-added industry.

The funds will be advanced with an upfront payment followed by two smaller installments based on the execution of short term Apo AIMilano development milestones expected to be completed by January 2010. The funds are repayable at the end of 18 months with interest.

"This funding comes at a very important time as it will contribute towards the achievement of near-term objectives for our Apo AIMilano candidate and allow us to leverage additional funding opportunities," said James Szarko, President and CEO of SemBioSys Genetics Inc. "AVAC's continued support reflects the shared vision of our enabling technology platform and its applicability to biopharmaceuticals like Apo AIMilano. This next-generation drug has the potential to meet a very large unmet need in cardiovascular disease. The terms of the funding provide us sufficient time to execute substantial value-generating milestones for this promising program."

"AVAC has very high hopes for SemBioSys' technology platform and has been a strong supporter of the Company since 2001. The Apo AIMilano product has true blockbuster potential and will provide the medical community with new tools to address the debilitating and potentially life-threatening consequences of atherosclerosis," says Jim Hardin, AVAC Investment Manager.

"In addition to its direct investments in early-stage companies, AVAC also participates in commercially-relevant agricultural research and we are the leading early-stage venture capital fund-of-fund investor in Alber
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. SemBioSys provides update on insulin program
2. SemBioSys Genetics Inc. Announces Clinical Results with Plant-Produced Insulin
3. SemBioSys announces senior management changes
4. SemBioSys receives US$2.5 million from option agreement with MannKind for plant-produced insulin
5. SemBioSys begins phase I/II trial of insulin produced in plant seeds
6. SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND
7. SemBioSys announces second quarter 2008 financial and operational results
8. SemBioSys submits IND for safflower-produced insulin to U.S. FDA
9. SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)
10. SemBioSys to present at the Needham & Company Biotechnology and Medical Technology Conference
11. SemBioSys provides update on shrimp feed additive, Immunosphere(TM)

Post Your Comments:

(Date:12/16/2009)... LLC introduces HSP-A Soy Peptone. HSP A has been found ... ... (PRWEB) December 16, 2009 -- Nu-Tek BioSciences, LLC. ( ... HSP-A Soy Peptone. HSP-A, previously manufactured by Nutricepts, Inc. (Burnsville, ... to improve growth rates and yields. HSP-A has been found ...

(Date:12/15/2009)... Epeius Biotechnologies Corporation, an emerging leader ... international validation of the cutting-edge science behind its ... around the world rediscovered the Cyclin G1 ... cancer pathogenesis and disease progression, and thus a ... the NIH National Cancer Institute investigating the role ...

(Date:12/15/2009)... Corporation (Nasdaq: RGEN ) today announced that ... to support the ongoing development of new treatments ... (MDA). This grant will support the completion ... of a drug candidate for human clinical trials. ... important funding for Repligen,s research but it also ...

(Date:12/15/2009)... Reportlinker.com announces that a new market research ... The Future of Orphan Diseases ... Analysis and Reimbursement ,, ... Summary ,, The author has released ... Diseases Therapeutics - Market Forecasts to 2015, ...

[0] Nu-Tek BioSciences, LLC. Launches Animal-Free, Non-GM Soy Peptone [0] Scientists Rediscover Gene Target for Cancer Therapy [0] Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program [0] Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement

... China, May 6 /Xinhua-PRNewswire-FirstCall/ -- Benda,Pharmaceutical, Inc. ... producing both Gendicine(R), a commercialized gene,therapy medicine ... Chinese and,conventional medicines, today filed an amendment ... Securities and Exchange Commission ("SEC"). The,amendment covers ...

... Inc. (Nasdaq: CALP ) today announced that ... Care Conference in Boston,Massachusetts, will be webcast on ... President and CEO of Caliper, will be providing ... can be accessed at, http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=CALP&item_id=18275 ,63. An archived ...

... Otsuka ... America Pharmaceutical, Inc., ROCKVILLE, Md., May 6 The American ... recipients of the fifth annual APF Awards for Advancing Minority,Mental Health. ... D.C. Each organization or individual was presented a plaque,along with an ...

Other Biology Technology:Benda Pharmaceutical Files Amendment To Form S-1 2 American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 2 American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 3 American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 4 American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 5

Benda Pharmaceutical Files Amendment To Form S-1 Caliper Life Sciences to Present at Deutsche Bank's 33rd Annual Health Care Conference American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health

(Date:12/15/2009)... The 2009 Frost & Sullivan ... presented to Sagem Securite (Safran Group) for ... award recognises the company,s expertise in advanced ... offering novel, value-added products to end users. ... ,, "Sagem Securite has been involved in ...

(Date:12/15/2009)... brain diseases such as Alzheimer,s and Parkinson,s, doctors can ... help a patient. , But they come up empty-handed ... patients with ataxia disabling disorders that rob people ... neurologists are trying to change that with the help ... Institute of Neurological Disorders and Stroke to establish a ...

(Date:12/15/2009)... environmental impacts, social dynamics, and production levels are ... of an agroecosystem. Positive or negative, these factors ... social groups to continuously adapt farming and food ... learning theory suggests that knowledge is gained as ... are especially valuable for environmental and agricultural educators ...

Breaking Biology News(10 mins):Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2 Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3 Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4 UF to lead national effort to help patients with rare brain disease 2 UF to lead national effort to help patients with rare brain disease 3 Experiential learning teaches change and adaptation 2 Carnegie Mellon Researchers Develop Novel Tool to Rank Death Rates 55462 1 Carnegie Mellon Researchers Develop Novel Tool to Rank Death Rates 55462 2 Carnegie Mellon Researchers Develop Novel Tool to Rank Death Rates 55462 3 Carnegie Mellon Researchers Develop Novel Tool to Rank Death Rates 55462 4 UPDATE 3A Spokane Washington Man Indicted on Civil Rights Charges Related to Threats to Reproductive Health Services Clinic 55459 1 California Life Science Business and Economic Development Experts Discuss Californias Bioscience Future 13708 1 California Life Science Business and Economic Development Experts Discuss Californias Bioscience Future 13708 2

[0] Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems [0] UF to lead national effort to help patients with rare brain disease [0] Experiential learning teaches change and adaptation

... Cincinnati, OH, August 13, 2008Dairy is recognized as a key ... it was unclear how long-term dairy intake contributes to the ... bone mineral content, and bone area. A new study ... investigates the effect of childhood dairy intake on adolescent ...

... hepatitis B infects 400 million people worldwide, many of ... B remains a stubborn, unrelenting health problem, especially in ... complications cause an estimated 1 million deaths globally each ... required for the current vaccines are costly and hard ...

... Ind. - Researchers have discovered an unusual molecule ... break down pollutants, especially the compounds that cause ... by this molecule, however, that will attract the ... University of Pennsylvania,s Edmund J. Kahn Distinguished Professor, ...

Other Biology News:Childhood dairy intake may improve adolescent bone health 2 Nano vaccine for hepatitis B shows promise for third world 2 Nano vaccine for hepatitis B shows promise for third world 3 Strange molecule in the sky cleans acid rain, scientists discover 2 Strange molecule in the sky cleans acid rain, scientists discover 3

Childhood dairy intake may improve adolescent bone health Nano vaccine for hepatitis B shows promise for third world Strange molecule in the sky cleans acid rain, scientists discover

...

... Spin Columns provide a rapid and simple method ... bp to 10 kb) from stained agarose gels ... excised from an agarose gel and loaded into ... the column are a series of membranes and ...

... The SpinPrep Gel DNA Kit enables efficient extraction ... bp in size from agarose gels. The procedure uses ... adsorption of the DNA to a silica membrane in ... purified DNA is eluted in low-salt buffer. Each spin ...

When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human HLA-DR TAC is designed to deplete human HLA-DR from samples to isolate resting CD4+ or CD8+ T cells....

Biology Products:

iQ Imaging Software from Andor Technology GenElute Minus EtBr Spin Column from Sigma-Aldrich SpinPrep Gel DNA Kit from Novagen StemSep Anti-Hu HLA-DR Tetramer, 200 uL from StemCell Technologies, Inc.

SemBioSys Genetics Inc. obtains up to $1.5 million in funding...( CALGARY May 4 / SemBioSys Genetics In...)